Providing Non-Invasive Choices to Individuals with
Poor Circulation
*With
gracious funds from the USDA our product is still in development, not ready to
sell or market yet. FDA approval is expected 2023 with sales to follow.
Providing Non-Invasive Choices to Individuals with
Poor Circulation
*With
gracious funds from the USDA our product is still in development, not ready to
sell or market yet. FDA approval is expected 2023 with sales to follow.